用于治疗良性前列腺增生的α受体阻滞剂
Alpha-blockers for the Treatment of Benign Prostatic Hyperplasia.
作者信息
Lepor Herbert
机构信息
NYU Langone Medical Center, NYU School of Medicine, 150 East 32nd Street, 2nd Floor, New York, NY 10016, USA.
出版信息
Urol Clin North Am. 2016 Aug;43(3):311-23. doi: 10.1016/j.ucl.2016.04.009.
PMID:27476124
Abstract
Over the last 2 decades the evolution of alpha-blockers for lower urinary tract symptoms (LUTS)/benign prostatic hyperplasia (BPH) has been to preserve effectiveness, improve tolerability, and eliminate dose titration. Today, alpha-blockers represent the first-line treatment of most men with BPH whereby the primary objective is relief from bothersome LUTS.
摘要
在过去20年里，用于治疗下尿路症状（LUTS）/良性前列腺增生（BPH）的α受体阻滞剂不断演进，目标是保持疗效、提高耐受性并消除剂量滴定。如今，α受体阻滞剂是大多数BPH男性患者的一线治疗药物，其主要目标是缓解令人困扰的LUTS。
Zotero 插件